Home » Newsletters » BioWorld

BioWorld

Feb. 17, 1994

View Archived Issues

ZONAGEN TEAMS UP WITH INDIAN COMPANY

IMUTEC'S VIRULIZIN TO ENTER PHASE III IN CANADA

ATS'S UNDERWRITERS EXERCISE OPTION

HYAL COMPLETES $8M PRIVATE PLACEMENT

CORRECTIONS

CELL GENESYS LICENSES GENE-ACTIVATED FSH TO AKZO

RESEARCHER EXPLORES SEROTONIN RECEPTORS

USDA APPROVES CALGENE'S HERBICIDE-RESISTANT COTTON

NEUROBIOLOGICAL TECHNOLOGIES RAISES $12.8 MILLION

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026